Join us on April 23rd for our 2025 Global Metals & Minerals Project Spending Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
Member Resources
COVID-19 Drives Increased Pharma-Bio Diagnostics Facility Spending

SUGAR LAND--April 12, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The diagnostics cohort of the Pharmaceutical-Biotech Industry, namely in vitro diagnostics (IVD) tests, are considered medical devices. Diagnostic products may be reagents, techniques, instruments, or a combination of these used in vitro for the examination of specimens such as blood, urine or tissue with the goal of obtaining a diagnosis from assays in a controlled environment outside a living organism. Industrial Info's Pharma/Bio group is currently tracking 93 active U.S. and Canada diagnostics substances projects with a total investment value of $1.56 billion.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

All Members Receive the Vlauable Resources

All Members Receive the Following Resources:

  • Industry News Digest
  • Upcoming Podcasts
  • On-Demand Podcasts
  • The NavigatIIR Newsletter
  • Economic Indicators
View All Member Resources
IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×
Contact Us

For More Info!